E
VSTM icon

Ergoteles’s Verastem VSTM Stock Holding History

Ergoteles’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,323
Closed -$25.7K – 1787
2022
Q4 		$25.7K Sell
5,323
-51,728
-91% -$254K ﹤0.01% 1336
2022
Q3 		$582K Sell
57,051
-12,284
-18% -$171K 0.02% 696
2022
Q2 		$965K Buy
69,335
+52,383
+309% +$834K 0.03% 557
2022
Q1 		$287K Buy
16,952
+9,460
+126% +$163K 0.01% 855
2021
Q4 		$184K Buy
+7,492
New +$236K 0.01% 1060

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Ergoteles's VSTM Position: Q1 2023 in Review

Ergoteles sold out of Verastem (VSTM) in Q1 2023, closing a stake of 5,323 shares — an estimated $25.7K sold.

Ergoteles first reported a position in VSTM in Q4 2021 and held it in 5 quarters. The position peaked at $965K in Q2 2022. 80 funds tracked by Wall St. Rank hold VSTM as of Q1 2023.

  • Ergoteles reported no remaining Verastem position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 5,323 Verastem shares in Q1 2023, an estimated $25.7K.
  • Ergoteles first reported a position in Verastem in Q4 2021 and held it in 5 quarters.
  • Ergoteles's Verastem position peaked at $965K in Q2 2022.
  • 80 funds tracked by Wall St. Rank held Verastem as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.